IRLAB Therapeutics AB Share Price OTC Markets
Stocks
IRLAF
SE0012675361
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 08/07 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 01/07 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
| Market Cap | 23Cr 2.38Cr 2.06Cr 1.92Cr 1.76Cr 3.32Cr 226.4Cr 3.37Cr 8.85Cr 113.48Cr 8.93Cr 8.74Cr 375.14Cr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 23Cr 2.38Cr 2.06Cr 1.92Cr 1.76Cr 3.32Cr 226.4Cr 3.37Cr 8.85Cr 113.48Cr 8.93Cr 8.74Cr 375.14Cr | EV / Sales 2026 * |
2.21x | EV / Sales 2027 * | 1.59x |
| Free-Float |
81.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IRLAB Therapeutics AB
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 01/08/2024 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 01/01/2013 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 01/01/2016 |
| Chairman | 73 | 07/05/2020 | |
| Chairman | 68 | 20/02/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.38Cr | |
| -0.52% | +3.21% | +89.52% | +127.32% | 1,05700Cr | |
| +0.88% | +1.13% | +49.56% | +49.69% | 62TCr | |
| +0.89% | -1.95% | +24.23% | +64.44% | 43TCr | |
| +0.71% | +3.87% | +49.07% | +37.85% | 36TCr | |
| +0.64% | -0.49% | +33.94% | +40.01% | 30TCr | |
| +0.39% | -5.83% | +8.92% | +7.85% | 25TCr | |
| +1.51% | +6.69% | +42.58% | +57.57% | 22TCr | |
| +3.92% | -0.46% | -5.56% | -52.32% | 21TCr | |
| +1.80% | +2.30% | +11.56% | +66.35% | 17TCr | |
| Average | +1.02% | +0.87% | +33.76% | +44.31% | 40.23TCr | |
| Weighted average by Cap. | +0.66% | +1.22% | +48.72% | +64.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10Cr 1.08Cr 93.1L 86.94L 79.75L 1.5Cr 102.43Cr 1.52Cr 4Cr 51Cr 4.04Cr 3.95Cr 169.73Cr | 14Cr 1.5Cr 1.29Cr 1.21Cr 1.11Cr 2.09Cr 142.4Cr 2.12Cr 5.57Cr 71Cr 5.62Cr 5.5Cr 235.96Cr |
| Net income | -3.26Cr -34.4L -29.75L -27.79L -25.49L -47.94L -33Cr -48.7L -1.28Cr -16Cr -1.29Cr -1.26Cr -54Cr | 3.33Cr 35.14L 30.39L 28.38L 26.04L 48.97L 33Cr 49.75L 1.31Cr 17Cr 1.32Cr 1.29Cr 55Cr |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IRLAB A Stock
- IRLAF Stock
Select your edition
All financial news and data tailored to specific country editions
